Immunohistochemical study of metallothionein in pancreatic carcinomas

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 6, 1996, Pages 351-355

  Ohshio, Gakuji ^a   Imamura, Takashi ^a   Okada, Noriyuki ^a   Wang, Zhao Hui ^a   Yamaki, Kenichirou ^a   Kyogoku, Takahisa ^a   Suwa, Hirofumi ^a   Yamabe, Hirohiko ^b   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cisplatin; Metallothionein; Pancreatic cancer

Indexed keywords

CISPLATIN; METALLOTHIONEIN;

ARTICLE; DRUG SENSITIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PRIORITY JOURNAL;

ADULT; CARCINOMA, DUCTAL, BREAST; HUMANS; IMMUNOHISTOCHEMISTRY; METALLOTHIONEIN; PANCREAS; PANCREATIC NEOPLASMS;

EID: 0030000198     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01220802     Document Type: Article

References (30)

1. Bahnson RR, Banner BF, Ernstoff MS, Lazo JS, Cherian MG, Banerjee D, Chin JL (1991) Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol 146:1528-1520
2. Bakka A, Enresen L, Johnsen ABS, Edminson PD, Rugstad HE (1981) Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol 61:215-226
3. Banerjee D, Onosaka S, Cherian MG (19821 Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 24:95-105
4. Bremner I, Williams RB, Young BW (1977) Distribution of copper and zinc in the liver of the developing fetus. Br J Nutr 38:87-92
5. Chin JL, Banerjee D, Kadhim SA, Kontozoglou TE, Chauvin PJ, Cherian MG (1993) Metallothionein in testicular germ cell tumors and drug resistance. Clin Correl Cancer 72:3029-3035
6. Collier JD, Bennett MK, Hall A, Cattan AR, Lendrum R, Bassendine MF (1994) Expression of glutathione S-transferases in normal and malignant pancreas: an immunohistochemical study. Gut 35:266-269
7. Dougherty JB, Kelsen D, Kemeny M, Magill G, Botet J, Niedzwiecki D (1989) Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine. J Natl Cancer Inst 81:1735-1737
8. Gibson JB (1978) Histological typing of tumours of the liver, biliary tract and pancreas. International histological classification of tumours. World Health Organization, Geneva
9. Haerslev T, Jakobsen K, Nedergaard L, Zedeler K (1994) Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Pathol Res Pract 190:675-681
10. Hamilton C, Winker MA, Louie KG, Batist G, Behrens BC, Tsuruo T, Grotzinger KR, McKoy WM, Young RC, Ozols RF (1985) Augmentation of Adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 34:2583-2586
11. Kagi JHR, Schäffer A (1988) Biochemistry of metallothionein. Biochemistry 27:8509-8515
12. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N (1991) Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 51:3237-3242
13. Karin M (1985) Metallothioneins: proteins in search of function. Cell 41:9-10
14. Kelley S, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science 241:1813-1815
15. Kloppel G, Lingenthal G, Vonbulow M, Kern HF (1985) Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology 9:841-856
16. Kraker A, Schmidt J, Krezoski S, Petering H (1985) Binding of cis-dichlorodiammine platinum (II) to metallothionein in Ehrlich cells. Biochem Biophys Res Commun 130:786-792
17. Masuda H, Ozols RF, Lai MG, Fojo A, Rothenberg M, Hamilton TC (1988) Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res 48:5713-5716
18. Meitner PA (1991) The fluoresecent cytoprint assay: a new approach to in vitro chemosensitivity testing. Oncology 5:75-81
19. Moertel CG, Rubin J, O'Connell MJ, Schutt AJ, Wieand HS (1986) A phase II study of combined 5-fluorouracil, doxorubicin and cisplatin in the treatment of upper gastrointestinal adenocarcinoma. J Clin Oncol 4:1053-1057
20. Morton K, Jones BJ, Sohn MH, Datz FL, Lynch RE (1993) Enrichment for metallothionein does not confer resistance to cisplatin in transfected NIH 3T3 cells. J Pharmacol Ther 267:697-702
21. Nartey N, Cherian MG, Banerjee D (1987) Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Pathol 129:177-182
22. Öfner D, Maier H, Riedmann, B, Bammer T, Rumer A, Winde G, Böcker W, Jasani B, Schmid KW (1994) Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch [A] 425:491-497
23. Ohshio G, Yoshioka H, Manabe T, Sakahara H, Yamabe H, Imamura M, Inoue M, Tanaka N, Nakada H, Yamashina I (1994) Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract. J Cancer Res Clin Oncol 29:325-330
24. Richon VM, Schulte N, Eastman A (1987) Multiple mechanisms of resistance to cis-diamminedichloroplatinum (II) in murine leukemia L1210 cells. Cancer Res 47:2056-2961
25. Ryden L, Deutsch HF (1978) Preparation and properties of the major copper-binding component in human fetal liver. J Biol Chem 253:519-524
26. Sato M, Bremner I (1993) Oxygen free radicals and metallothionein. Free Radical Biol Med 14:325-337
27. Schilder RJ, Hall L, Monks A, Hancel LM, Fornace AJ Jr, Ozols RF, Fojo AT, Hamilton TC (1990) Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int J Cancer 45:416-422
28. Wils JA, Kok T, Wagener DJTh, Selleslags J, Duez N (1993) Activity of cisplatin in adenocarcinoma of the pancreas. Eur J Cancer 29A:203-204
29. Zelazowski AJ, Garvey JS, Hoeschele JD (1984) In vivo and in vitro binding of platinum to metallothionein. Arch Biochem Biophys 229:246-252
30. Zeiger B, Hittmair A, Schir M, Öfner C, Öfner D, Fritsch PO, Böcker W, Jasani B, Schmid KW (1993) Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 23:257-264